Insider Title Company Date Price Return Shares Value
Devroe Eric Chief Operating Officer Acrivon Therapeutics, Inc. (ACRV) 2026-01-13 $1.72 0.0% 10,000 $17,218
Return Profit / (loss) Cost
Total 0.0% $0 $17,218